Influenza virus characterisation, Summary Europe, June 2016
Since week 40/2015, almost 139 000 influenza detections across the Region have been reported. Influenza type A viruses have prevailed over type B with A(H1N1)pdm09 viruses, greatly outnumbering A(H3N2) and B/Victoria-lineage detections representing over 91% of the type B viruses assigned to a lineage. Since 1 January 2016, EU/EEA countries have shared 498 influenza-positive specimens with the Francis Crick Institute, London, for detailed characterisation. Since the May report, 160 viruses have been characterised antigenically, and genetic analyses are ongoing.
Of the 63 A(H1N1)pdm09 viruses characterised antigenically, 60 (95%) were similar to the vaccine virus A/California/7/2009. Worldwide new genetic subclusters of viruses within the 6B clade have emerged, with two being designated as subclades: 6B.1 defined by HA1 amino acid substitutions S162N and I216T, and 6B.2 defined by HA1 amino acid substitutions V152T and V173I. Of the 381 viruses characterised genetically for the 2015–2016 season, 29 (8%) were clade 6B, 344 (90%) were subclade 6B.1, and eight (2%) were subclade 6B.2.
The 25 A(H3N2) test viruses characterised by haemagglutination inhibition (HI) assay were poorly recognised by reference antiserum raised against egg-propagated A/Switzerland/9715293/2013, the vaccine virus recommended for use in the 2015–2016 northern hemisphere influenza season. The test viruses were recognised somewhat better by antisera raised against egg-propagated A/Hong Kong/4801/2014, the virus recommended for use in 2016 southern hemisphere and 2016-2017 northern hemisphere influenza vaccines. Of 114 A(H3N2) viruses characterised genetically for the 2015–2016 season: two (2%) were clade 3C.3, 84 (74%) were subclade 3C.2a, and 28 (24%) were subclade 3C.3a.
The 63 B/Victoria-lineage viruses were antigenically similar to tissue culture-propagated surrogates of B/Brisbane/60/2008. All 159 viruses characterised genetically for the 2015–2016 season fell in genetic clade 1A, as do recently collected viruses worldwide.
Nine B/Yamagata viruses have been characterised since the previous report; they reacted well with post-infection ferret antiserum raised against egg-propagated B/Phuket/3073/2013, the recommended vaccine virus for the northern hemisphere 2015–2016 influenza season and for quadrivalent vaccines in the 2016 southern hemisphere and 2016–2017 northern hemisphere seasons. Of the 25 viruses characterised genetically for the 2015–2016 season, 24 fell in genetic clade 3 and one in clade 2.
Influenza virus characterisation, Summary Europe, June 2018
18 Jul 2018 - This is the sixth report of the 2017–18 influenza season. As of week 25/2018, nearly 239 000 influenza detections across the WHO European Region have been reported.
Influenza virus characterisation, Summary Europe, May 2018
2 Jul 2018 - This is the fifth report of the 2017–18 influenza season. As of week 20/2018, nearly 240 000 influenza detections across the WHO Europe region have been reported.
Influenza virus characterisation, Summary Europe, March 2018
4 Jun 2018 - The ECDC Influenza Virus Characterisations Reports are published periodically and provides an overview of the technical details of the circulating influenza viruses, such as antigenic and genetic properties, with a reference to the current vaccine strains. It also summaries the developments of the viruses since the last report, as well as the main developments for the ongoing season.